Trials / Completed
CompletedNCT04740645
NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden
Post-authorisation Safety Study of NOCDURNA for the Symptomatic Treatment of Nocturia Due to Idiopathic Nocturnal Polyuria: A Multi-country Cohort Study Using Secondary Data
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,099,551 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study using medical records to evaluate safety issues for the NOCDURNA drug using national register data from Denmark and Sweden, and a health care register covering parts of Germany.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NOCDURNA Cohort | Non intervention |
| OTHER | LUTS Cohort | Non intervention |
Timeline
- Start date
- 2021-07-13
- Primary completion
- 2023-11-01
- Completion
- 2023-11-01
- First posted
- 2021-02-05
- Last updated
- 2025-12-03
Locations
3 sites across 3 countries: Denmark, Germany, Sweden
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04740645. Inclusion in this directory is not an endorsement.